Latest news
OncoSil Medical (ASX:OSL) Soars ~16%—Could This Be the Breakthrough Moment Investors Were Waiting For? - KalkineKalkine · Mon, 03 Aug 2026 06:52:00 GMTOncoSil Medical (ASX:OSL): An 'Overnight Success' Decades in the Making as Manufacturing and FDA Decision Loom - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTOncosil Medical Posts FY26 Unit Sales Up 53%, Revenue Up 44% Versus FY25 - TradingViewTradingView · Thu, 30 Jul 2026 02:14:00 GMTOncoSil Medical (ASX: OSL): FDA Decision Nears - KalkineKalkine · Wed, 29 Jul 2026 12:44:00 GMTOncoSil (ASX:OSL) Wins TGA Approval for Pancreatic Cancer Device - KalkineKalkine · Wed, 29 Jul 2026 08:05:00 GMTOncoSil Medical Slips as Its Pancreatic Cancer Device Reaches the FDA's Door - KalkineKalkine · Tue, 28 Jul 2026 07:00:00 GMTOncoSil Medical (ASX: OSL) Advances FDA Submission as Manufacturing and Commercial Expansion Remain Key Focus - KalkineKalkine · Tue, 28 Jul 2026 07:00:00 GMTOncoSil study shows higher particle loads may not affect injectability - BiotechDispatchBiotechDispatch · Tue, 28 Jul 2026 00:31:57 GMT